Spots Global Cancer Trial Database for The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol
Official Title: An Open-label, Crossover Study of the Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol
Study ID: NCT03892018
Conditions
Interventions
Study Description
Brief Summary: This is multicenter, open-label, 2-part crossover study. Eligible subjects will have metastatic or unresectable solid tumors. This study includes a pretreatment and treatment phase. The pretreatment phase consists of screening and baseline. The treatment phase consists of Periods 1 and 2 (Part A), Treatment (Part B), and Follow-up.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Beatson West of Scotland Cancer Care Centre, Glasgow, , United Kingdom
The Christie NHS Foundation Trust, Manchester, , United Kingdom
The Northern Institute for Cancer Care, Newcastle Upon Tyne, , United Kingdom
Contact Details
Name: David Cutler, MD
Affiliation: Athenex, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
